Get notified when AHR files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: AHR American Healthcare REIT, Inc. 10-Q

Total revenues rose 29.5% to $742.1M in the third quarter, while net income attributable to controlling interest fell 44.2% to $31.2M.

Filed November 6, 2026 · Period ending September 30, 2026 · Compared to 10-Q Nov 7, 2025 · ~1 min read

Key Changes

  • high

    Net income attributable to controlling interest declined 44.2% to $31.2M, or $0.14 per diluted share, from $0.33 a year earlier.

  • high

    The company received $2.30B in gross proceeds from common stock offerings during the nine months ended September 30, 2026, and total stockholders' equity increased to $5.54B as of September 30, 2026.

  • medium

    The company is under contract to acquire two additional real estate properties for an aggregate purchase price of $301.00B, which it expects to fund with proceeds from equity offerings.

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (OWL 10-Q) is open in full — no account needed.

Partner

Trade AHR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Nov 9, 2026 · How we verify